Sunday, March 11, 2018

PARIS (Reuters) - Sanofi and Evotec said they had started exclusive talks over accelerating research into the treatment of infectious diseases, and added on Thursday that they would form a new open innovation platform in this area, led by Evotec.


from Reuters: Health News http://ift.tt/2FAaUsY

Related Posts:

  • LATEST HEALTH NEWS(Reuters Health) - Use of prescription opioids remains high in the U.S., despite public health efforts and growing awareness of risks for abuse and overdose, a new study suggests. from Reuters: Health News https://ift.tt… Read More
  • LATEST HEALTH NEWS(Reuters Health) - Roughly two in three U.S. teens believe that tougher gun control laws might help prevent mass shootings, a survey suggests. from Reuters: Health News https://ift.tt/2LUme6p … Read More
  • LATEST HEALTH NEWSPrivately held Celtaxsys Inc said on Thursday a mid-stage trial testing its experimental cystic fibrosis treatment was successful in reducing a key symptom of the genetic lung disease, but did not improve lung function. … Read More
  • LATEST HEALTH NEWSHONG KONG (Reuters/IFR) - Chinese Nasdaq-listed biotech BeiGene Ltd has raised $903 million after pricing its secondary listing in Hong Kong - the first under new exchange rules - near the top of an indicative range, three pe… Read More
  • LATEST HEALTH NEWSThe European Medicines Agency estimates there could be one extra case of cancer for every 5,000 patients taking a common blood pressure and heart drug manufactured in bulk by a Chinese company that has been found to contain a… Read More

0 comments:

Post a Comment

Followers

Contact Form

Name

Email *

Message *

Popular Posts

FOLLOW BY EMAIL

Enter your email address:

Delivered by FeedBurner